48
Participants
Start Date
January 31, 2015
Primary Completion Date
October 31, 2015
Study Completion Date
October 31, 2015
RTS,S/AS01B (50mcg of RTS,S and standard adult dose of AS01)
RTS,S/AS01B (10mcg of RTS,S and one fifth of the standard dose of AS01)
ChAd63 ME-TRAP (5 x 10^10 vp)
MVA ME-TRAP (2 x 10^8 pfu)
NIHR WTCRF, University Hospital Southampton NHS Foundation Trust, Southampton
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford
Surrey Clinical Research Centre, University of Surrey, Guildford
NIHR/Wellcome Trust Imperial CRF, Hammersmith Hospital, Imperial College NHS Trust, London
The PATH Malaria Vaccine Initiative (MVI)
OTHER
National Institute for Health Research, United Kingdom
OTHER_GOV
University of Oxford
OTHER